BA
The Boeing Company
BA has the edge over ORN overall, supported by stronger fundamentals and stronger valuation.
ORN
Orion Group Holdings, Inc.
ORN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ORN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Under pressure |
ORN's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over ORN in the historical PE scenario, which offers more potential upside but is not a forecast.
ORN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $1.40 | -82% |
| Fair | 21x | $3.30 | -57% |
| Forward | 27x | $7.65 | — |
| Current | 48x | $7.65 | — |
| Expensive | 85x | $13.65 | +78% |
Historical ranges are pointers, not guarantees.
ORN's PE is in its expensive range at 48x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over ORN on the outlook, with more favorable profitability expectations.
ORN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ORN, with profitability holding steady. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
ORN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.28 | +76% |
| Q3 2026 | $0.16 | -43% |
| Q2 2026 | $0.10 | -69% |
| Q1 2026 | $0.22 | +120% |
| Q4 2025 | $0.06 | +$0.11 |
| Q3 2025 | $0.28 | +$0.68 |
| Q2 2025 | $0.32 | +$0.86 |
| Q1 2025 | $0.10 | +$0.45 |
| Q4 2024 | -$0.05 | +$0.50 |
ORN has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over ORN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
ORN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $256.2M | +14% |
| Q2 2026 | $221.9M | +8.1% |
| Q1 2026 | $216.3M | +15% |
| Q4 2025 | $233.2M | +7.5% |
| Q3 2025 | $225.1M | -0.7% |
| Q2 2025 | $205.3M | +6.8% |
| Q1 2025 | $188.7M | +17% |
| Q4 2024 | $216.9M | +7.6% |
ORN's revenue has grown year over year for four quarters in a row: $256M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.3% | +1 points |
| Q2 2026 | -0.6% | -2.3 points |
| Q1 2026 | -0.4% | -0.8 points |
| Q4 2025 | 2.1% | -2.3 points |
| Q3 2025 | 2.4% | -1.1 points |
| Q2 2025 | 1.7% | +3.1 points |
| Q1 2025 | 0.4% | +2.4 points |
| Q4 2024 | 4.4% | +4.7 points |
ORN has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over ORN on cash generation, producing positive trailing cash flow while its opponent burns cash.
ORN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6M | -143% |
| Q2 2026 | -$29.2M | -$16.5M |
| Q1 2026 | -$3.7M | +$8.8M |
| Q4 2025 | $454K | -95% |
| Q3 2025 | $13.9M | -58% |
| Q2 2025 | -$12.7M | +$7.3M |
| Q1 2025 | -$12.5M | +$12.2M |
| Q4 2024 | $9.9M | -77% |
ORN has burned cash in most quarters: −$38M over the past year, against −$1M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over ORN on leverage, with a lower net debt burden relative to earnings.
ORN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.4x | Elevated |
| Q2 2026 | 3.8x | Elevated |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | -0.2x | Net Cash |
ORN's net debt is about 3.4 years of its operating earnings (EBITDA), up from less than a year a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ORN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 13.2 | Oversold |
ORN's weekly RSI is 34 (neutral) and its Stochastic is 13 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over ORN on valuation relative to its sector.
ORN PE vs Industrials Sector
| Metric | ORN | Sector median | Relative |
|---|---|---|---|
| PE | 48x | 24x | 99% above |
| PE % | 67 | 58 | 9 pts above |
ORN is trading at 48x earnings, a 99% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ORN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.44 | 9.4% below |
| 20 week MA | $9.89 | 23% below |
| 50 week MA | $11.5 | 33% below |
| 100 week MA | $9.65 | 21% below |
| 200 week MA | $7.62 | 0.4% above |
ORN has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over ORN on returns for 2026, with the stronger performance.
ORN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.00 | $4.94 | -1.2% |
| 2021 | $4.94 | $3.78 | -23% |
| 2022 | $3.78 | $2.29 | -39% |
| 2023 | $2.29 | $4.94 | +116% |
| 2024 | $4.94 | $7.53 | +52% |
| 2025 | $7.53 | $10.4 | +38% |
| 2026 YTD | $10.4 | $7.65 | -27% |
ORN has finished lower in three of the last six years. It's down 27% so far in 2026.